Lemaitre Vascular Inc Shares Climb 2.5% Past Previous 52-Week High - Market Mover
The shares rose 2.5% higher than its previous 52-week high of $55.04, with trading volume lower than its 30 day average
Jun 11, 2021 by Kwhen Finance Editors
Lemaitre Vascular Inc (LMAT) shares closed 2.5% higher than its previous 52 week high, giving the company a market cap of $1B. The stock is currently up 36.4% year-to-date, up 114.4% over the past 12 months, and up 284.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 1.2%.
Trading Activity
- Trading volume this week was 14.6% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.6.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
- The stock closed at 4.1% higher than its 5-day moving average, 10.2% higher than its 20-day moving average, and 13.5% higher than its 90-day moving average.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Lemaitre Vascular Inc | 2.6 | 36.4 | 114.4 | 0.6 | 137.5 |
| Dow Jones Industrial Average | 0.0 | 13.6 | 30.1 | -1.3 | 41.6 |
| S&P 500 Index | 0.2 | 13.7 | 34.9 | -0.1 | 45.2 |
| Health Care | -0.8 | 10.7 | 24.5 | -0.3 | 33.3 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by 150.8%
- The company's stock price performance over the past 12 months beats the peer average by 225.9%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Lemaitre Vascular Inc | LMAT | 0 | 36.4 | 114.4 | 0.6 | 137.5 |
| Peer Avg | N/A | 67.6 | 14.5 | 35.1 | -6.9 | 63.4 |
| Edwards Lifesciences Corp | EW | 73.0 | 9.5 | 36.4 | -0.4 | 50.3 |
| Boston Scientific Corp. | BSX | 301.3 | 19.2 | 14.3 | -4.2 | 29.6 |
| Baxter International Inc. | BAX | 39.6 | 5.5 | -1.9 | -6.7 | 13.8 |
| Teleflex Incorporated | TFX | 66.4 | -3.5 | 8.5 | -11.9 | 26.9 |
| Cardiovascular Systems Inc. | CSII | -68.8 | -8.8 | 20.9 | -16.9 | 44.9 |
| Angiodynamic Inc | ANGO | -5.7 | 65.2 | 132.5 | -1.6 | 214.9 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: